苏可
肾内
副主任医师，硕士生导师
副主任医师，硕士生导师
导师介绍
| 姓名 | 苏可 |
| 出生年月 | 1985年8月 |
| 单位 | 武汉大学人民医院肾病内科 |
| 所属学科 | 临床医学-内科学 |
| 职务、职称及头衔 | 副主任医师，硕士生导师 |
| suke@whu.edu.cn | |
| 联系方式 | 027-88041911转81396 |
| 研究方向 |
1.糖尿病肾病的发病机制 2.慢性肾衰竭的诊疗 |
| 个人简介 | 主要从事肾脏疾病的诊治与科研工作，获国家自然科学基金1项。参编规划教材《病理生理学》，以第一作者发表论文10余篇，其中SCI论文7篇，其中二区以上3篇。 |
| 学术任职与荣誉 | 湖北省微循环学会血液净化血管通路委员会 委员 |
| 教育履历 |
2003.09-2008.06武汉大学医学院临床医学专业本科生获学士学位 2008.09-2013.06武汉大学医学院病理生理学专业硕博连读获博士学位 |
| 工作履历 |
2013.07-2019.12武汉大学人民医院肾病内科主治医师 2020.01-至今武汉大学人民医院肾病内科副主任医师 2021.07-至今加拿大蒙特利尔大学访问学者 |
| 成果获奖 | |
| 代表性论著 |
1.Su
Ke, Yi Bo, Yao Biqing, Xia Tian, Yang Yifei, Zhang Zhihao, Chen Cheng;
Liraglutide attenuates renal tubular ectopic lipid deposition in rats with
diabetic nephropathy by inhibiting lipid synthesis and promoting lipolysis,
Pharmacological Research, 2020, 156: 104778.
2.Su Ke, Ma Yiqiong, Wang Yujuan, Song Yuan, Lv Xifen, Wei Zhongping,
Shi Ming, Ding Guohua, Shen Bo, Wang,
Huiming; How we mitigated and contained the COVID-19 outbreak in a
hemodialysis center: Lessons and experience. Infection Control and Hospital
Epidemiology, 2020 Oct;41(10):1240-1242. 3.Su Ke, Zeng Ping, Liang Wei, Luo Zhengyu, Wang Yiman, Lv Xifeng, Han Qi, Yan Miao, Chen Cheng*; FTY720 Attenuates Angiotensin II-Induced Podocyte Damage via Inhibiting Inflammatory Cytokines, Mediators of Inflammation, 2017:1-14. 4.Su Ke, Hu Pengchao, Wang Xiaolan, Kuang Changchun, Xiang Qingmin, Yang Fang, Xiang Jin, Zhu Shan, Wei Lei, Zhang Jingwei*; Tumor suppressor berberine binds VASP to inhibit cell migration in basal-like breast cancer, Oncotarget, 2016, 7(29): 45849-45862. 5.Su Ke, Lv Xifen, Song Hui, Luo Xuesong, Chen Cheng*; PCB77 Inducing Renal Tubular Cell Apoptosis, Ultrastructural Pathology, 2015, 39(3):192-197. 6.Zhang Jingwei#, Su Ke#, Shi Wentao, Wang Ying, Hu Pengchao, Wei Lei, Xiang Jing, Yang Fang. Matrine inhibits the adhesion and migration of BCG823 gastric cancer cells by affecting the structure and function of the vasodilator-stimulated phosphoprotein (VASP). Acta Pharmacol Sin, 2013, 34(8):1084-1092. 7. Su Ke, Tian Yihao, Wang Jing, Shi Wentao, Luo Daji, Liu Jian, Tong Zan, Wu Junzhu, Zhang Jingwei, Wei Lei: HIF-1alpha acts downstream of TNF-alpha to inhibit vasodilator-stimulated phosphoprotein expression and modulates the adhesion and proliferation of breast cancer cells. DNA Cell Biol 2012, 31(6):1078-1087 8.苏可，易波，姚碧晴，夏甜，陈铖*.(2019/12).利拉鲁肽通过抑制固醇调节元件结合蛋白-1减轻糖尿病肾病大鼠肾小管异位脂肪沉积.中华糖尿病杂志, 2019(12):774-781 |
| Name | KE SU |
| Date of birth | Aug，1985 |
| Department | Nephrology Department，Renmin Hospital,Wuhan University. |
| Title | associate senior doctor，master tutor |
| suke@whu.edu.cn | |
| TEL | 027-88041911-81396 |
| Research Direction |
1.
Pathogenesis of diabetic nephropathy 2. Diagnosis and treatment of chronic renal failure |
| Personal Profile | I am mainly engaged in the diagnosis and treatment of kidney diseases and scientific research work, won a national natural science fund.Participated in the compilation of the planned textbook Pathophysiology, and published more than 10 papers as the first author, including 7 SCI papers and 3 papers were published on top journal. |
| Selected Publications |
1.Su
Ke, Yi Bo, Yao Biqing, Xia Tian, Yang Yifei, Zhang Zhihao, Chen Cheng;
Liraglutide attenuates renal tubular ectopic lipid deposition in rats with
diabetic nephropathy by inhibiting lipid synthesis and promoting lipolysis,
Pharmacological Research, 2020, 156: 104778.
2.Su Ke, Ma Yiqiong, Wang Yujuan, Song Yuan, Lv Xifen, Wei Zhongping,
Shi Ming, Ding Guohua, Shen Bo, Wang,
Huiming; How we mitigated and contained the COVID-19 outbreak in a
hemodialysis center: Lessons and experience. Infection Control and Hospital
Epidemiology, 2020 Oct;41(10):1240-1242. 3.Su Ke, Zeng Ping, Liang Wei, Luo Zhengyu, Wang Yiman, Lv Xifeng, Han Qi, Yan Miao, Chen Cheng*; FTY720 Attenuates Angiotensin II-Induced Podocyte Damage via Inhibiting Inflammatory Cytokines, Mediators of Inflammation, 2017:1-14. 4.Su Ke, Hu Pengchao, Wang Xiaolan, Kuang Changchun, Xiang Qingmin, Yang Fang, Xiang Jin, Zhu Shan, Wei Lei, Zhang Jingwei*; Tumor suppressor berberine binds VASP to inhibit cell migration in basal-like breast cancer, Oncotarget, 2016, 7(29): 45849-45862. 5.Su Ke, Lv Xifen, Song Hui, Luo Xuesong, Chen Cheng*; PCB77 Inducing Renal Tubular Cell Apoptosis, Ultrastructural Pathology, 2015, 39(3):192-197. 6.Zhang Jingwei#, Su Ke#, Shi Wentao, Wang Ying, Hu Pengchao, Wei Lei, Xiang Jing, Yang Fang. Matrine inhibits the adhesion and migration of BCG823 gastric cancer cells by affecting the structure and function of the vasodilator-stimulated phosphoprotein (VASP). Acta Pharmacol Sin, 2013, 34(8):1084-1092. 7. Su Ke, Tian Yihao, Wang Jing, Shi Wentao, Luo Daji, Liu Jian, Tong Zan, Wu Junzhu, Zhang Jingwei, Wei Lei: HIF-1alpha acts downstream of TNF-alpha to inhibit vasodilator-stimulated phosphoprotein expression and modulates the adhesion and proliferation of breast cancer cells. DNA Cell Biol 2012, 31(6):1078-1087 8.苏可，易波，姚碧晴，夏甜，陈铖*.(2019/12).利拉鲁肽通过抑制固醇调节元件结合蛋白-1减轻糖尿病肾病大鼠肾小管异位脂肪沉积.中华糖尿病杂志, 2019(12):774-781 |
武汉大学人民医院
湖北省人民医院